The Clinical Observation Of Treating Hypomenorrhea (Syndrome Of Deficiency Of Both QI And Blood) For The New Lvjiao Buxue Granules

Objective:To evaluate the clinical effect and security of The new Lvjiao buxue Granules in treating hypomenorrhea (syndrome of deficiency of both QI and blood), to provide the basis for the application.Methods:44 patients suffered by the hypomenorrhea (syndrome of deficiency of both QI and blood) were selected, randomly divided into test group and control group with double-blind, positive control method. Test group were treated with The new Lvjiao buxue Granules, control group with Lvjiao buxue Granules, for 12 weeks. The clinical symptoms and signs. related curative effect data and security data of tow groups were observed both before and after treatment.Results:A. Hypomenorrhea effect: For test group, the evident cure rate (ECR) is 50%. total efficiency rate (TER) is 95.45%, control group respectively 38.09%,76.19%,The difference was statistically significant (P<0.05) in the same group.There is no significant difference between tow groups by the analysis of SPSS 16.0(P>0.05). B.Symptoms effection:The ECR of test group is 45.45%, TER is 100%: control group respectively 42.85%,85.71%. The difference was statistically significant (P<0.05) in the same group.There is no significant difference between tow groups by the analysis of SPSS 16.0. (P>0.05).C,Safety analysis:There has not seen other serious adverse reactions cases and other unusual physico-chemical test parameters which has the clinical significance. So the usage of The new Lvjiao buxue Granules for clinic is safe.Conclusions:The new Lvjiao buxue Granules in treating hypomenorrhea (syndrome of deficiency of both QI and blood) can obviously improve symptoms including the light color and the dilute texture of menstrual and the fatigue symptoms. It is worth further studying and spreading widely to clinical application with the characteristic of security, high efficiency and fine stability.